Securities and Exchange Commission
Washington, D.C. 20549
Form 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d/16 of
the Securities Exchange Act of 1934
February 2012
AEGON N.V.
AEGONplein 50
2591 TV THE HAGUE
The Netherlands
AEGONs condensed consolidated interim financial statements Q4 2011, is included as an exhibit and incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AEGON N.V. | ||||||
(Registrant) | ||||||
Date: February 17, 2012 | By | /s/ E. Lagendijk | ||||
E. Lagendijk | ||||||
Executive Vice President and General Counsel |
Exhibit A
CONDENSED CONSOLIDATED
INTERIM FINANCIAL STATEMENTS
Q4 2011
TABLE OF CONTENTS
Condensed consolidated income statement |
p 2 | |||
Condensed consolidated statement of comprehensive income |
p 3 | |||
Condensed consolidated statement of financial position |
p 4 | |||
Condensed consolidated statement of changes in equity |
p 5 | |||
Condensed consolidated cash flow statement |
p 6 | |||
Notes to the condensed consolidated interim financial statements |
p 7 |
Unaudited |
Page 1 |
CONDENSED CONSOLIDATED INCOME STATEMENT
EUR millions (except per share data) |
Notes | Q4 2011 | Q4 2010 | FY 2011 | FY 2010 | |||||||||||||||
Premium income |
4 | 4,437 | 4,777 | 19,521 | 21,097 | |||||||||||||||
Investment income |
5 | 2,043 | 2,032 | 8,167 | 8,762 | |||||||||||||||
Fee and commission income |
6 | 481 | 476 | 1,465 | 1,744 | |||||||||||||||
Other revenues |
1 | 2 | 6 | 5 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
6,962 | 7,287 | 29,159 | 31,608 | ||||||||||||||||
Income from reinsurance ceded |
7 | 892 | 475 | 2,775 | 1,869 | |||||||||||||||
Results from financial transactions |
8 | 5,873 | 4,208 | (187 | ) | 15,662 | ||||||||||||||
Other income |
9 | 5 | 6 | 39 | 40 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total income |
13,732 | 11,976 | 31,786 | 49,179 | ||||||||||||||||
Benefits and expenses |
10 | 13,291 | 11,224 | 29,856 | 46,057 | |||||||||||||||
Impairment charges / (reversals) |
11 | 176 | 317 | 483 | 701 | |||||||||||||||
Interest charges and related fees |
130 | 95 | 491 | 426 | ||||||||||||||||
Other charges |
12 | 53 | (1 | ) | 69 | 122 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total charges |
13,650 | 11,635 | 30,899 | 47,306 | ||||||||||||||||
Share in net result of associates |
4 | 11 | 29 | 41 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Income / (loss) before tax |
86 | 352 | 916 | 1,914 | ||||||||||||||||
Income tax (expense) / benefit |
(5 | ) | (34 | ) | (44 | ) | (154 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net income / (loss) |
81 | 318 | 872 | 1,760 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net income / (loss) attributable to: |
||||||||||||||||||||
Equity holders of AEGON N.V. |
79 | 318 | 869 | 1,759 | ||||||||||||||||
Non-controlling interests |
2 | | 3 | 1 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Earnings and dividend per share (EUR per share) |
||||||||||||||||||||
Earnings per share 1 |
0.02 | 0.16 | (0.06 | ) | 0.83 | |||||||||||||||
Earnings per share, excluding premium on convertible core capital securities |
0.02 | 0.16 | 0.34 | 0.86 | ||||||||||||||||
Diluted earnings per share 1, 2 |
0.02 | 0.16 | (0.06 | ) | 0.83 | |||||||||||||||
Earnings per share after potential attribution to convertible core capital securities 1, 3 |
| 0.14 | | 0.76 | ||||||||||||||||
Diluted earnings per share after conversion of convertible core capital securities 1, 2 |
| 0.13 | | 0.68 | ||||||||||||||||
Dividend per common share |
| | | | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net income / (loss) per common share calculation |
||||||||||||||||||||
Net income / (loss) |
79 | 318 | 869 | 1,759 | ||||||||||||||||
Preferred dividend |
| | (59 | ) | (90 | ) | ||||||||||||||
Coupons on perpetuals |
(45 | ) | (45 | ) | (177 | ) | (187 | ) | ||||||||||||
Coupons and premium on convertible core capital securities |
| | (750 | ) | (63 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Earnings attributable to common shareholders |
34 | 273 | (117 | ) | 1,419 | |||||||||||||||
Potential coupon on convertible core capital securities |
| (32 | ) | | (127 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Earnings after potential attribution to convertible core capital securities |
34 | 241 | (117 | ) | 1,292 | |||||||||||||||
Weighted average number of common shares outstanding |
1,880 | 1,707 | 1,852 | 1,707 | ||||||||||||||||
Weighted average number of common shares outstanding, after conversion of convertible core capital securities |
| 2,082 | | 2,165 |
1 | After deduction of preferred dividend, coupons on perpetuals and coupons and premium on core capital securities. |
2 | The potential conversion of the convertible core capital securities is taken into account in the calculation of diluted earnings per share if this would have a dilutive effect (i.e. diluted earnings per share would be lower than the earnings after potential attribution to convertible core capital securities). |
3 | Reflect basic earnings per share. For Q4 2011, basic earnings per share is EUR 0.02 |
Unaudited |
Page 2 |
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
EUR millions |
Q4 2011 | Q4 2010 | FY 2011 | FY 2010 | ||||||||||||
Net income / (loss) |
81 | 318 | 872 | 1,760 | ||||||||||||
Other comprehensive income: |
||||||||||||||||
Gains / (losses) on revaluation of available-for-sale investments |
1,265 | (2,128 | ) | 3,113 | 3,873 | |||||||||||
(Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investments |
(175 | ) | 32 | (513 | ) | (203 | ) | |||||||||
Changes in revaluation reserve real estate held for own use |
| | 3 | 4 | ||||||||||||
Changes in cash flow hedging reserve |
151 | 120 | 1,058 | 373 | ||||||||||||
Movement in foreign currency translation and net foreign investment hedging reserve |
550 | 331 | 409 | 1,054 | ||||||||||||
Equity movements of associates |
(10 | ) | (35 | ) | (18 | ) | (25 | ) | ||||||||
Disposal of group assets |
| | | (22 | ) | |||||||||||
Aggregate tax effect of items recognized in other comprehensive income |
(377 | ) | 576 | (1,167 | ) | (1,409 | ) | |||||||||
Other |
| 1 | 4 | (10 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income for the period |
1,404 | (1,103 | ) | 2,889 | 3,635 | |||||||||||
Total comprehensive income |
1,485 | (785 | ) | 3,761 | 5,395 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income attributable to: |
||||||||||||||||
Equity holders of AEGON N.V. |
1,483 | (785 | ) | 3,758 | 5,394 | |||||||||||
Non-controlling interests |
2 | | 3 | 1 |
Unaudited |
Page 3 |
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
EUR millions |
Notes | Dec. 31, 2011 |
Dec. 31, 2010 |
|||||||||
ASSETS |
||||||||||||
Intangible assets |
13 | 3,285 | 4,359 | |||||||||
Investments |
14 | 144,079 | 143,188 | |||||||||
Investments for account of policyholders |
15 | 142,529 | 146,237 | |||||||||
Derivatives |
16 | 15,504 | 6,251 | |||||||||
Investments in associates |
742 | 733 | ||||||||||
Reinsurance assets |
17 | 11,517 | 5,580 | |||||||||
Deferred expenses and rebates |
18 | 11,633 | 11,948 | |||||||||
Other assets and receivables |
8,184 | 8,695 | ||||||||||
Cash and cash equivalents |
8,104 | 5,231 | ||||||||||
|
|
|
|
|||||||||
Total assets |
345,577 | 332,222 | ||||||||||
EQUITY AND LIABILITIES |
||||||||||||
Shareholders equity |
21,000 | 17,328 | ||||||||||
Convertible core capital securities |
20 | | 1,500 | |||||||||
Other equity instruments |
4,720 | 4,704 | ||||||||||
|
|
|
|
|||||||||
Issued capital and reserves attributable to equity holders of AEGON N.V. |
25,720 | 23,532 | ||||||||||
Non-controlling interests |
14 | 11 | ||||||||||
|
|
|
|
|||||||||
Group equity |
25,734 | 23,543 | ||||||||||
Trust pass-through securities |
159 | 143 | ||||||||||
Subordinated borrowings |
18 | | ||||||||||
Insurance contracts |
105,175 | 100,506 | ||||||||||
Insurance contracts for account of policyholders |
73,425 | 77,650 | ||||||||||
Investment contracts |
20,847 | 23,237 | ||||||||||
Investment contracts for account of policyholders |
71,433 | 69,527 | ||||||||||
Derivatives |
16 | 12,728 | 5,971 | |||||||||
Borrowings |
21 | 10,141 | 8,518 | |||||||||
Other liabilities |
25,917 | 23,127 | ||||||||||
|
|
|
|
|||||||||
Total liabilities |
319,843 | 308,679 | ||||||||||
|
|
|
|
|||||||||
Total equity and liabilities |
345,577 | 332,222 | ||||||||||
|
|
|
|
Unaudited |
Page 4 |
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
EUR millions |
Share capital 1 |
Retained earnings |
Revaluation reserves |
Other reserves |
Convertible core capital securities |
Other equity instruments |
Issued capital and reserves 2 |
Non- controlling interests |
Total | |||||||||||||||||||||||||||
Full year ended December 31, 2011 |
||||||||||||||||||||||||||||||||||||
At beginning of year |
8,184 | 9,529 | 958 | (1,343 | ) | 1,500 | 4,704 | 23,532 | 11 | 23,543 | ||||||||||||||||||||||||||
Net income recognized in the income statement |
| 869 | | | | | 869 | 3 | 872 | |||||||||||||||||||||||||||
Other comprehensive income: |
||||||||||||||||||||||||||||||||||||
Gains / (losses) on revaluation of available-for-sale investments |
| | 3,113 | | | | 3,113 | | 3,113 | |||||||||||||||||||||||||||
(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
| | (513 | ) | | | | (513 | ) | | (513 | ) | ||||||||||||||||||||||||
Changes in revaluation reserve real estate held for own use |
| | 3 | | | | 3 | | 3 | |||||||||||||||||||||||||||
Changes in cash flow hedging reserve |
| | 1,058 | | | | 1,058 | | 1,058 | |||||||||||||||||||||||||||
Movement in foreign currency translation and net foreign investment hedging reserves |
| | | 409 | | | 409 | | 409 | |||||||||||||||||||||||||||
Equity movements of associates |
| | | (18 | ) | | | (18 | ) | | (18 | ) | ||||||||||||||||||||||||
Aggregate tax effect of items recognized in other comprehensive income |
| | (1,155 | ) | (12 | ) | | | (1,167 | ) | | (1,167 | ) | |||||||||||||||||||||||
Other |
| 4 | | | | | 4 | | 4 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total other comprehensive income |
| 4 | 2,506 | 379 | | | 2,889 | | 2,889 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total comprehensive income for 2011 |
| 873 | 2,506 | 379 | | | 3,758 | 3 | 3,761 | |||||||||||||||||||||||||||
Shares issued |
913 | | | | | | 913 | | 913 | |||||||||||||||||||||||||||
Repurchase of convertible core capital securities |
| | | | (1,500 | ) | | (1,500 | ) | | (1,500 | ) | ||||||||||||||||||||||||
Preferred dividend |
| (59 | ) | | | | | (59 | ) | | (59 | ) | ||||||||||||||||||||||||
Coupons on perpetuals |
| (177 | ) | | | | | (177 | ) | | (177 | ) | ||||||||||||||||||||||||
Coupons and premium on convertible core capital securities |
| (750 | ) | | | | | (750 | ) | | (750 | ) | ||||||||||||||||||||||||
Share options and incentive plans |
| | | | | 16 | 16 | | 16 | |||||||||||||||||||||||||||
Other |
| (13 | ) | | | | | (13 | ) | | (13 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
At end of period |
9,097 | 9,403 | 3,464 | (964 | ) | | 4,720 | 25,720 | 14 | 25,734 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Full year ended December 31, 2010 |
||||||||||||||||||||||||||||||||||||
At beginning of year |
8,184 | 8,103 | (1,709 | ) | (2,304 | ) | 2,000 | 4,709 | 18,983 | 10 | 18,993 | |||||||||||||||||||||||||
Net income / (loss) recognized in the income statement |
| 1,759 | | | | | 1,759 | 1 | 1,760 | |||||||||||||||||||||||||||
Other comprehensive income: |
||||||||||||||||||||||||||||||||||||
Gains / (losses) on revaluation of available-for-sale investments |
| | 3,873 | | | | 3,873 | | 3,873 | |||||||||||||||||||||||||||
(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
| | (203 | ) | | | | (203 | ) | | (203 | ) | ||||||||||||||||||||||||
Changes in revaluation reserve real estate held for own use |
| | 4 | | | | 4 | | 4 | |||||||||||||||||||||||||||
Changes in cash flow hedging reserve |
| | 373 | | | | 373 | | 373 | |||||||||||||||||||||||||||
Movement in foreign currency translation and net foreign investment hedging reserves |
| | | 1,054 | | | 1,054 | | 1,054 | |||||||||||||||||||||||||||
Equity movements of associates |
| | | (25 | ) | | | (25 | ) | | (25 | ) | ||||||||||||||||||||||||
Disposal of group assets |
| | (22 | ) | | | | (22 | ) | | (22 | ) | ||||||||||||||||||||||||
Aggregate tax effect of items recognized in other comprehensive income |
| | (1,358 | ) | (51 | ) | | | (1,409 | ) | | (1,409 | ) | |||||||||||||||||||||||
Other |
| 7 | | (17 | ) | | | (10 | ) | | (10 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total other comprehensive income |
| 7 | 2,667 | 961 | | | 3,635 | | 3,635 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total comprehensive income / (loss) for 2010 |
| 1,766 | 2,667 | 961 | | | 5,394 | 1 | 5,395 | |||||||||||||||||||||||||||
Repayment convertible core capital securities |
| | | | (500 | ) | | (500 | ) | | (500 | ) | ||||||||||||||||||||||||
Preferred dividend |
| (90 | ) | | | | | (90 | ) | | (90 | ) | ||||||||||||||||||||||||
Coupons on perpetual securities |
| (187 | ) | | | | | (187 | ) | | (187 | ) | ||||||||||||||||||||||||
Coupons and premium on convertible core capital securities |
| (63 | ) | | | | | (63 | ) | | (63 | ) | ||||||||||||||||||||||||
Share options and incentive plans |
| | | | | (5 | ) | (5 | ) | | (5 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
At end of period |
8,184 | 9,529 | 958 | (1,343 | ) | 1,500 | 4,704 | 23,532 | 11 | 23,543 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 | For a breakdown of share capital please refer to note 19. |
2 | Issued capital and reserves attributable to equity holders of AEGON N.V. |
Unaudited |
Page 5 |
CONDENSED CONSOLIDATED CASH FLOW STATEMENT
EUR millions |
FY 2011 | FY 2010 | ||||||
Cash flow from operating activities |
2,266 | 1,263 | ||||||
Purchases and disposals of intangible assets |
(17 | ) | (18 | ) | ||||
Purchases and disposals of equipment and other assets |
(54 | ) | (83 | ) | ||||
Purchases, disposals and dividends of subsidiaries and associates |
724 | (177 | ) | |||||
|
|
|
|
|||||
Cash flow from investing activities |
653 | (278 | ) | |||||
Issuance and purchase of share capital |
913 | | ||||||
Dividends paid |
(59 | ) | (90 | ) | ||||
Issuances, repurchases and coupons of convertible core capital securities |
(2,250 | ) | (563 | ) | ||||
Issuances, repurchases and coupons of perpetuals |
(237 | ) | (251 | ) | ||||
Issuances and repayments on borrowings |
1,259 | 1,023 | ||||||
|
|
|
|
|||||
Cash flow from financing activities |
(374 | ) | 119 | |||||
Net increase / (decrease) in cash and cash equivalents |
2,545 | 1,104 | ||||||
|
|
|
|
|||||
Net cash and cash equivalents at January 1 |
5,174 | 4,013 | ||||||
Effects of changes in exchange rate |
107 | 57 | ||||||
|
|
|
|
|||||
Net cash and cash equivalents at end of period |
7,826 | 5,174 | ||||||
|
|
|
|
|||||
Dec. 31, 2011 |
Dec. 31, 2010 |
|||||||
Cash and cash equivalents |
8,104 | 5,231 | ||||||
Bank overdrafts |
(278 | ) | (57 | ) | ||||
|
|
|
|
|||||
Net cash and cash equivalents |
7,826 | 5,174 | ||||||
|
|
|
|
Unaudited |
Page 6 |
Notes to the condensed consolidated interim financial statements
Amounts in EUR millions, unless otherwise stated
Unaudited |
Page 7 |
Unaudited |
Page 8 |
3. Segment information
3.1 Income statement
Three months ended December 31, 2011
EUR millions |
Americas | The Netherlands |
United Kingdom |
New Markets |
Holding and other activities |
Eliminations | Non-IFRS Total |
Associates eliminations |
Total IFRS based |
|||||||||||||||||||||||||||
Three months ended December 31, 2011 |
||||||||||||||||||||||||||||||||||||
Underlying earnings before tax geographically |
328 | 75 | (26 | ) | 53 | (84 | ) | | 346 | (4 | ) | 342 | ||||||||||||||||||||||||
Fair value items |
(139 | ) | 189 | 3 | (10 | ) | (63 | ) | | (20 | ) | | (20 | ) | ||||||||||||||||||||||
Realized gains / (losses) on investments |
8 | 33 | 8 | | | | 49 | | 49 | |||||||||||||||||||||||||||
Impairment charges |
(70 | ) | (5 | ) | | (23 | ) | | | (98 | ) | 2 | (96 | ) | ||||||||||||||||||||||
Impairment reversals |
4 | | | | | | 4 | | 4 | |||||||||||||||||||||||||||
Other income / (charges) |
(36 | ) | (84 | ) | (57 | ) | 1 | (18 | ) | | (194 | ) | | (194 | ) | |||||||||||||||||||||
Run-off businesses |
1 | | | | | | 1 | | 1 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Income before tax |
96 | 208 | (72 | ) | 21 | (165 | ) | | 88 | (2 | ) | 86 | ||||||||||||||||||||||||
Income tax (expense) / benefit |
4 | (60 | ) | (16 | ) | (5 | ) | 70 | | (7 | ) | 2 | (5 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net income |
100 | 148 | (88 | ) | 16 | (95 | ) | | 81 | | 81 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Inter-segment underlying earnings |
(31 | ) | (62 | ) | (16 | ) | 55 | 54 | ||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
1,643 | 379 | 1,490 | 364 | | | 3,876 | (71 | ) | 3,805 | ||||||||||||||||||||||||||
Accident and health insurance |
463 | 30 | | 11 | | | 504 | 1 | 505 | |||||||||||||||||||||||||||
General insurance |
| 94 | | 33 | | | 127 | | 127 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total gross premiums |
2,106 | 503 | 1,490 | 408 | | | 4,507 | (70 | ) | 4,437 | ||||||||||||||||||||||||||
Investment income |
910 | 597 | 488 | 64 | 115 | (113 | ) | 2,061 | (17 | ) | 2,044 | |||||||||||||||||||||||||
Fee and commission income |
306 | 78 | 29 | 120 | | (53 | ) | 480 | | 480 | ||||||||||||||||||||||||||
Other revenues |
| | | (1 | ) | 2 | | 1 | | 1 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total revenues |
3,322 | 1,178 | 2,007 | 591 | 117 | (166 | ) | 7,049 | (87 | ) | 6,962 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Inter-segment revenues |
2 | 1 | | 53 | 110 |
Three months ended December 31, 2010
EUR millions |
Americas | The Netherlands |
United Kingdom |
New Markets |
Holding and other activities |
Eliminations | Non-IFRS Total |
Associates eliminations |
Total IFRS based |
|||||||||||||||||||||||||||
Three months ended December 31, 2010 |
||||||||||||||||||||||||||||||||||||
Underlying earnings before tax geographically |
369 | 87 | (6 | ) | 59 | (57 | ) | | 452 | (3 | ) | 449 | ||||||||||||||||||||||||
Fair value items |
8 | 18 | | | 4 | | 30 | | 30 | |||||||||||||||||||||||||||
Realized gains / (losses) on investments |
247 | 1 | 8 | | (1 | ) | | 255 | | 255 | ||||||||||||||||||||||||||
Impairment charges |
(115 | ) | (1 | ) | (24 | ) | (11 | ) | | | (151 | ) | | (151 | ) | |||||||||||||||||||||
Impairment reversals |
17 | 1 | | | | | 18 | | 18 | |||||||||||||||||||||||||||
Other income / (charges) |
(200 | ) | 5 | (13 | ) | (40 | ) | (11 | ) | 1 | (258 | ) | | (258 | ) | |||||||||||||||||||||
Run-off businesses |
9 | | | | | | 9 | | 9 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Income before tax |
335 | 111 | (35 | ) | 8 | (65 | ) | 1 | 355 | (3 | ) | 352 | ||||||||||||||||||||||||
Income tax (expense) / benefit |
(40 | ) | (30 | ) | 16 | 1 | 16 | | (37 | ) | 3 | (34 | ) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net income |
295 | 81 | (19 | ) | 9 | (49 | ) | 1 | 318 | | 318 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Inter-segment underlying earnings |
(40 | ) | (20 | ) | (18 | ) | 70 | 8 | ||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
1,707 | 516 | 1,674 | 367 | | | 4,264 | (125 | ) | 4,139 | ||||||||||||||||||||||||||
Accident and health insurance |
465 | 27 | | 18 | | | 510 | (1 | ) | 509 | ||||||||||||||||||||||||||
General insurance |
| 94 | | 35 | | | 129 | | 129 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total gross premiums |
2,172 | 637 | 1,674 | 420 | | | 4,903 | (126 | ) | 4,777 | ||||||||||||||||||||||||||
Investment income |
987 | 530 | 471 | 58 | 83 | (79 | ) | 2,050 | (18 | ) | 2,032 | |||||||||||||||||||||||||
Fee and commission income |
278 | 89 | 43 | 135 | | (69 | ) | 476 | | 476 | ||||||||||||||||||||||||||
Other revenues |
| | | 2 | | | 2 | | 2 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total revenues |
3,437 | 1,256 | 2,188 | 615 | 83 | (148 | ) | 7,431 | (144 | ) | 7,287 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Inter-segment revenues |
| | 1 | 69 | 78 |
Unaudited |
Page 9 |
Full year ended December 31, 2011
EUR millions |
Americas | The Netherlands |
United Kingdom |
New Markets |
Holding and other activities |
Eliminations | Non-IFRS Total |
Associates eliminations |
Total IFRS based |
|||||||||||||||||||||||||||
Full year ended December 31, 2011 |
||||||||||||||||||||||||||||||||||||
Underlying earnings before tax geographically |
1,310 | 298 | 5 | 212 | (306 | ) | 3 | 1,522 | (13 | ) | 1,509 | |||||||||||||||||||||||||
Fair value items |
(478 | ) | 156 | (6 | ) | (29 | ) | (59 | ) | | (416 | ) | | (416 | ) | |||||||||||||||||||||
Realized gains / (losses) on investments |
124 | 269 | 51 | 2 | | | 446 | | 446 | |||||||||||||||||||||||||||
Impairment charges |
(307 | ) | (16 | ) | (62 | ) | (58 | ) | | | (443 | ) | 4 | (439 | ) | |||||||||||||||||||||
Impairment reversals |
54 | 1 | | | | | 55 | | 55 | |||||||||||||||||||||||||||
Other income / (charges) |
(35 | ) | (164 | ) | (57 | ) | 7 | (18 | ) | | (267 | ) | | (267 | ) | |||||||||||||||||||||
Run-off businesses |
28 | | | | | | 28 | | 28 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Income before tax |
696 | 544 | (69 | ) | 134 | (383 | ) | 3 | 925 | (9 | ) | 916 | ||||||||||||||||||||||||
Income tax (expense) / benefit |
(26 | ) | (125 | ) | 17 | (50 | ) | 131 | | (53 | ) | 9 | (44 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net income |
670 | 419 | (52 | ) | 84 | (252 | ) | 3 | 872 | | 872 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Inter-segment underlying earnings |
(124 | ) | (105 | ) | (68 | ) | 224 | 73 | ||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
6,232 | 3,213 | 6,474 | 1,317 | | | 17,236 | (383 | ) | 16,853 | ||||||||||||||||||||||||||
Accident and health insurance |
1,780 | 216 | | 71 | | | 2,067 | | 2,067 | |||||||||||||||||||||||||||
General insurance |
| 452 | | 149 | | | 601 | | 601 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total gross premiums |
8,012 | 3,881 | 6,474 | 1,537 | | | 19,904 | (383 | ) | 19,521 | ||||||||||||||||||||||||||
Investment income |
3,638 | 2,192 | 2,154 | 247 | 315 | (308 | ) | 8,238 | (70 | ) | 8,168 | |||||||||||||||||||||||||
Fee and commission income |
749 | 329 | 137 | 464 | | (215 | ) | 1,464 | | 1,464 | ||||||||||||||||||||||||||
Other revenues |
1 | | | 1 | 4 | | 6 | | 6 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total revenues |
12,400 | 6,402 | 8,765 | 2,249 | 319 | (523 | ) | 29,612 | (453 | ) | 29,159 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Inter-segment revenues |
6 | 2 | 2 | 215 | 298 |
Full year ended December 31, 2010
EUR millions |
Americas | The Netherlands |
United Kingdom |
New Markets |
Holding and other activities |
Eliminations | Non-IFRS Total |
Associates eliminations |
Total IFRS based |
|||||||||||||||||||||||||||
Full year ended December 31, 2010 |
||||||||||||||||||||||||||||||||||||
Underlying earnings before tax geographically |
1,459 | 385 | 72 | 200 | (283 | ) | | 1,833 | (9 | ) | 1,824 | |||||||||||||||||||||||||
Fair value items |
(24 | ) | 361 | (9 | ) | (10 | ) | (97 | ) | | 221 | | 221 | |||||||||||||||||||||||
Realized gains / (losses) on investments |
380 | 155 | 14 | 13 | 96 | | 658 | (2 | ) | 656 | ||||||||||||||||||||||||||
Impairment charges |
(464 | ) | (17 | ) | (39 | ) | (22 | ) | | | (542 | ) | | (542 | ) | |||||||||||||||||||||
Impairment reversals |
81 | 6 | 3 | | | | 90 | | 90 | |||||||||||||||||||||||||||
Other income / (charges) |
(306 | ) | 38 | 48 | (56 | ) | (34 | ) | 1 | (309 | ) | | (309 | ) | ||||||||||||||||||||||
Run-off businesses |
(26 | ) | | | | | | (26 | ) | | (26 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Income before tax |
1,100 | 928 | 89 | 125 | (318 | ) | 1 | 1,925 | (11 | ) | 1,914 | |||||||||||||||||||||||||
Income tax (expense) / benefit |
31 | (217 | ) | (5 | ) | (34 | ) | 60 | | (165 | ) | 11 | (154 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net income |
1,131 | 711 | 84 | 91 | (258 | ) | 1 | 1,760 | | 1,760 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Inter-segment underlying earnings |
(154 | ) | (51 | ) | (67 | ) | 248 | 24 | ||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
6,877 | 3,185 | 7,425 | 1,306 | | | 18,793 | (427 | ) | 18,366 | ||||||||||||||||||||||||||
Accident and health insurance |
1,850 | 201 | | 72 | | | 2,123 | (2 | ) | 2,121 | ||||||||||||||||||||||||||
General insurance |
| 451 | | 159 | | | 610 | | 610 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total gross premiums |
8,727 | 3,837 | 7,425 | 1,537 | | | 21,526 | (429 | ) | 21,097 | ||||||||||||||||||||||||||
Investment income |
4,073 | 2,161 | 2,340 | 234 | 305 | (279 | ) | 8,834 | (72 | ) | 8,762 | |||||||||||||||||||||||||
Fee and commission income |
998 | 348 | 164 | 479 | | (245 | ) | 1,744 | | 1,744 | ||||||||||||||||||||||||||
Other revenues |
1 | | | 4 | 1 | | 6 | (1 | ) | 5 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total revenues |
13,799 | 6,346 | 9,929 | 2,254 | 306 | (524 | ) | 32,110 | (502 | ) | 31,608 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Inter-segment revenues |
| 1 | 3 | 246 | 274 |
Unaudited |
Page 10 |
Unaudited |
Page 11 |
Unaudited |
Page 12 |
3.2 Investments geographically
At December 31, 2011
amounts in million EUR (unless otherwise stated) | ||||||||||||||||||||||||||||||||||||
Americas USD |
United Kingdom GBP |
At December 31, 2011 |
Americas | The Netherlands |
United Kingdom |
New Markets |
Holding & other activities |
Eliminations | Total EUR |
|||||||||||||||||||||||||||
Investments | ||||||||||||||||||||||||||||||||||||
1,570 | 45 | Shares | 1,209 | 505 | 54 | 60 | 11 | (2 | ) | 1,837 | ||||||||||||||||||||||||||
86,056 | 8,261 | Debt securities | 66,289 | 17,640 | 9,890 | 2,600 | | | 96,419 | |||||||||||||||||||||||||||
13,341 | 7 | Loans | 10,277 | 18,825 | 8 | 626 | | | 29,736 | |||||||||||||||||||||||||||
16,196 | | Other financial assets | 12,476 | 40 | | 43 | 744 | | 13,303 | |||||||||||||||||||||||||||
1,006 | | Investments in real estate | 775 | 2,009 | | | | | 2,784 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
118,169 | 8,313 | Investments general account | 91,026 | 39,019 | 9,952 | 3,329 | 755 | (2 | ) | 144,079 | ||||||||||||||||||||||||||
| 21,755 | Shares | | 7,608 | 26,045 | 3,459 | | (4 | ) | 37,108 | ||||||||||||||||||||||||||
| 10,003 | Debt securities | | 15,124 | 11,975 | 277 | | | 27,376 | |||||||||||||||||||||||||||
80,137 | 7,096 | Separate accounts and investment funds |
61,729 | | 8,495 | 1,060 | | | 71,284 | |||||||||||||||||||||||||||
| 2,940 | Other financial assets | | 491 | 3,519 | 1,619 | | | 5,629 | |||||||||||||||||||||||||||
| 946 | Investments in real estate | | | 1,132 | | | | 1,132 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
80,137 | 42,740 | Investments for account of policyholders |
61,729 | 23,223 | 51,166 | 6,415 | | (4 | ) | 142,529 | ||||||||||||||||||||||||||
198,306 | 51,053 | Investments on balance sheet | 152,755 | 62,242 | 61,118 | 9,744 | 755 | (6 | ) | 286,608 | ||||||||||||||||||||||||||
119,371 | | Off balance sheet investments third parties |
91,951 | | | 44,959 | | | 136,910 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
317,677 | 51,053 | Total revenue generating investments |
244,706 | 62,242 | 61,118 | 54,703 | 755 | (6 | ) | 423,518 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Investments | ||||||||||||||||||||||||||||||||||||
98,007 | 8,266 | Available-for-sale | 75,494 | 18,016 | 9,896 | 2,427 | 27 | | 105,860 | |||||||||||||||||||||||||||
13,341 | 7 | Loans | 10,277 | 18,825 | 8 | 626 | | | 29,736 | |||||||||||||||||||||||||||
| | Held-to-maturity | | | | 168 | | | 168 | |||||||||||||||||||||||||||
85,952 | 41,834 | Financial assets at fair value through profit or loss |
66,209 | 23,392 | 50,082 | 6,523 | 728 | (6 | ) | 146,928 | ||||||||||||||||||||||||||
1,006 | 946 | Investments in real estate | 775 | 2,009 | 1,132 | | | | 3,916 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
198,306 | 51,053 | Total investments on balance sheet | 152,755 | 62,242 | 61,118 | 9,744 | 755 | (6 | ) | 286,608 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
100 | 7 | Investments in associates | 77 | 52 | 9 | 600 | 4 | | 742 | |||||||||||||||||||||||||||
34,224 | 5,919 | Other assets | 26,363 | 19,403 | 7,086 | 2,011 | 36,725 | (32,516 | ) | 59,072 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
232,630 | 56,979 | Consolidated total assets | 179,195 | 81,697 | 68,213 | 12,355 | 37,484 | (32,522 | ) | 346,422 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The decline in off balance sheet investments third parties in The Netherlands, compared to December 31, 2010, reflect a transfer of third party asset management operations from AEGON The Netherlands to AEGON Asset Management, included in New Markets.
Unaudited |
Page 13 |
At December 31, 2010
amounts in million EUR (unless otherwise stated) |
||||||||||||||||||||||||||||||||||||
Americas USD |
United Kingdom GBP |
At December 31, 2010 |
Americas | The Netherlands |
United Kingdom |
New Markets |
Holding & other activities |
Eliminations | Total EUR |
|||||||||||||||||||||||||||
Investments | ||||||||||||||||||||||||||||||||||||
1,737 | 53 | Shares | 1,300 | 945 | 62 | 72 | | (3 | ) | 2,376 | ||||||||||||||||||||||||||
89,687 | 7,917 | Debt securities | 67,121 | 18,504 | 9,198 | 2,041 | | | 96,864 | |||||||||||||||||||||||||||
15,249 | 8 | Loans | 11,412 | 15,629 | 9 | 653 | | | 27,703 | |||||||||||||||||||||||||||
17,481 | | Other financial assets | 13,083 | 40 | | 45 | 293 | | 13,461 | |||||||||||||||||||||||||||
974 | | Investments in real estate | 729 | 2,055 | | | | | 2,784 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
125,128 | 7,978 | Investments general account | 93,645 | 37,173 | 9,269 | 2,811 | 293 | (3 | ) | 143,188 | ||||||||||||||||||||||||||
| 25,470 | Shares | | 8,087 | 29,589 | 3,139 | | (5 | ) | 40,810 | ||||||||||||||||||||||||||
| 13,573 | Debt securities | | 14,435 | 15,768 | 223 | | | 30,426 | |||||||||||||||||||||||||||
79,308 | 6,393 | Separate accounts and investment funds |
59,353 | | 7,427 | 1,309 | | | 68,089 | |||||||||||||||||||||||||||
| 3,250 | Other financial assets | | 536 | 3,775 | 1,467 | | | 5,778 | |||||||||||||||||||||||||||
| 976 | Investments in real estate | | | 1,134 | | | | 1,134 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
79,308 | 49,662 | Investments for account of policyholders |
59,353 | 23,058 | 57,693 | 6,138 | | (5 | ) | 146,237 | ||||||||||||||||||||||||||
204,436 | 57,640 | Investments on balance sheet | 152,998 | 60,231 | 66,962 | 8,949 | 293 | (8 | ) | 289,425 | ||||||||||||||||||||||||||
115,297 | | Off balance sheet investments third parties |
86,287 | 12,353 | | 25,126 | | | 123,766 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
319,733 | 57,640 | Total revenue generating investments |
239,285 | 72,584 | 66,962 | 34,075 | 293 | (8 | ) | 413,191 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Investments | ||||||||||||||||||||||||||||||||||||
102,792 | 7,899 | Available-for-sale | 76,929 | 19,261 | 9,177 | 1,879 | 4 | | 107,250 | |||||||||||||||||||||||||||
15,249 | 8 | Loans | 11,412 | 15,629 | 9 | 653 | | | 27,703 | |||||||||||||||||||||||||||
| | Held-to-maturity | | | | 139 | | | 139 | |||||||||||||||||||||||||||
85,421 | 48,757 | Financial assets at fair value through profit or loss |
63,928 | 23,286 | 56,642 | 6,278 | 289 | (8 | ) | 150,415 | ||||||||||||||||||||||||||
974 | 976 | Investments in real estate | 729 | 2,055 | 1,134 | | | | 3,918 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
204,436 | 57,640 | Total investments on balance sheet | 152,998 | 60,231 | 66,962 | 8,949 | 293 | (8 | ) | 289,425 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
114 | 8 | Investments in associates | 85 | 59 | 9 | 576 | 4 | | 733 | |||||||||||||||||||||||||||
27,238 | 5,415 | Other assets | 20,385 | 11,626 | 6,290 | 1,703 | 30,804 | (28,744 | ) | 42,064 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
231,788 | 63,063 | Consolidated total assets | 173,468 | 71,916 | 73,261 | 11,228 | 31,101 | (28,752 | ) | 332,222 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited |
Page 14 |
4. Premium income and premium to reinsurers
EUR millions |
Q4 2011 | Q4 2010 | FY 2011 | FY 2010 | ||||||||||||
Gross |
||||||||||||||||
Life |
3,805 | 4,139 | 16,853 | 18,366 | ||||||||||||
Non-Life |
632 | 638 | 2,668 | 2,731 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
4,437 | 4,777 | 19,521 | 21,097 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Reinsurance |
||||||||||||||||
Life |
891 | 417 | 3,042 | 1,509 | ||||||||||||
Non-Life |
93 | 88 | 365 | 350 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
984 | 505 | 3,407 | 1,859 | ||||||||||||
|
|
|
|
|
|
|
|
5. Investment income
EUR millions |
Q4 2011 | Q4 2010 | FY 2011 | FY 2010 | ||||||||||||
Interest income |
1,818 | 1,858 | 7,256 | 7,958 | ||||||||||||
Dividend income |
186 | 132 | 745 | 632 | ||||||||||||
Rental income |
39 | 42 | 166 | 172 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total investment income |
2,043 | 2,032 | 8,167 | 8,762 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Investment income related to general account |
1,494 | 1,501 | 5,823 | 6,258 | ||||||||||||
Investment income for account of policyholders |
549 | 531 | 2,344 | 2,504 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
2,043 | 2,032 | 8,167 | 8,762 | ||||||||||||
|
|
|
|
|
|
|
|
Unaudited |
Page 15 |
8. Results from financial transactions
EUR millions |
Q4 2011 | Q4 2010 | FY 2011 | FY 2010 | ||||||||||||
Net fair value change of general account financial investments at FVTPL other than derivatives |
18 | 108 | 44 | 257 | ||||||||||||
Realized gains and (losses) on financial investments |
222 | 66 | 803 | 564 | ||||||||||||
Gains and (losses) on investments in real estate |
(13 | ) | 186 | (49 | ) | 135 | ||||||||||
Net fair value change of derivatives |
259 | (1,243 | ) | 1,165 | 1,340 | |||||||||||
Net fair value change on for account of policyholder financial assets at FVTPL |
5,401 | 5,035 | (2,133 | ) | 13,217 | |||||||||||
Net fair value change on investments in real estate for account of policyholders |
7 | (15 | ) | 20 | 73 | |||||||||||
Net foreign currency gains and (losses) |
(6 | ) | (3 | ) | (17 | ) | 60 | |||||||||
Net fair value change on borrowings and other financial liabilities |
(15 | ) | 56 | (24 | ) | (2 | ) | |||||||||
Realized gains and (losses) on repurchased debt |
| 18 | 4 | 18 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
5,873 | 4,208 | (187 | ) | 15,662 | |||||||||||
|
|
|
|
|
|
|
|
9. Other income
In 2011, other income mainly relates to a benefit related to
a settlement of legal claims.
10. Benefits and expenses
EUR millions |
Q4 2011 | Q4 2010 | FY 2011 | FY 2010 | ||||||||||||
Claims and Benefits |
12,322 | 10,300 | 26,358 | 42,825 | ||||||||||||
Employee expenses |
502 | 538 | 2,069 | 2,151 | ||||||||||||
Administration expenses |
355 | 355 | 1,315 | 1,182 | ||||||||||||
Deferred expenses |
(353 | ) | (392 | ) | (1,458 | ) | (1,611 | ) | ||||||||
Amortization charges |
465 | 423 | 1,572 | 1,510 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
13,291 | 11,224 | 29,856 | 46,057 | ||||||||||||
|
|
|
|
|
|
|
|
Unaudited |
Page 16 |
11. Impairment charges / (reversals)
EUR millions |
Q4 2011 | Q4 2010 | FY 2011 | FY 2010 | ||||||||||||
Impairment charges / (reversals) comprise: |
||||||||||||||||
Impairment charges on financial assets, excluding receivables 1 |
107 | 160 | 461 | 615 | ||||||||||||
Impairment reversals on financial assets, excluding receivables 1 |
(4 | ) | (18 | ) | (55 | ) | (90 | ) | ||||||||
Impairment charges / (reversals) on non-financial assets and receivables |
73 | 175 | 77 | 176 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
176 | 317 | 483 | 701 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Impairment charges on financial assets, excluding receivables, from: |
||||||||||||||||
Shares |
2 | 3 | 10 | 7 | ||||||||||||
Debt securities and money market instruments |
61 | 99 | 345 | 475 | ||||||||||||
Loans |
43 | 44 | 99 | 114 | ||||||||||||
Other |
| 14 | 6 | 19 | ||||||||||||
Investments in associates |
1 | | 1 | | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
107 | 160 | 461 | 615 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Impairment reversals on financial assets, excluding receivables, from: |
||||||||||||||||
Debt securities and money market instruments |
(2 | ) | (6 | ) | (48 | ) | (73 | ) | ||||||||
Loans |
(2 | ) | (12 | ) | (7 | ) | (17 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
(4 | ) | (18 | ) | (55 | ) | (90 | ) | ||||||||
|
|
|
|
|
|
|
|
1 | Impairment charges / (reversals) on financial assets, excluding receivables, are excluded from underlying earnings before tax for segment reporting (refer to note 3). |
12. Other charges
13. Intangible assets
EUR millions |
Dec. 31, 2011 | Dec. 31, 2010 | ||||||
Goodwill |
753 | 652 | ||||||
VOBA |
2,086 | 3,221 | ||||||
Future servicing rights |
397 | 444 | ||||||
Software |
36 | 32 | ||||||
Other |
13 | 10 | ||||||
|
|
|
|
|||||
Total intangible assets |
3,285 | 4,359 | ||||||
|
|
|
|
Unaudited |
Page 17 |
14. Investments
EUR millions |
Dec. 31, 2011 | Dec. 31, 2010 | ||||||||||||||||||
Available-for-sale (AFS) |
105,860 | 107,250 | ||||||||||||||||||
Loans |
29,736 | 27,703 | ||||||||||||||||||
Held-to-maturity (HTM) |
168 | 139 | ||||||||||||||||||
Financial assets at fair value through profit or loss (FVTPL) |
5,531 | 5,312 | ||||||||||||||||||
|
|
|
|
|||||||||||||||||
Financial assets, excluding derivatives |
141,295 | 140,404 | ||||||||||||||||||
Investments in real estate |
2,784 | 2,784 | ||||||||||||||||||
|
|
|
|
|||||||||||||||||
Total investments for general account |
144,079 | 143,188 | ||||||||||||||||||
|
|
|
|
|||||||||||||||||
Total financial assets, excluding derivatives |
||||||||||||||||||||
AFS | FVTPL | HTM | Loans | Total | ||||||||||||||||
Shares |
869 | 968 | | | 1,837 | |||||||||||||||
Debt securities |
94,722 | 1,529 | 168 | | 96,419 | |||||||||||||||
Money market and other short term investments |
9,382 | 1,090 | | | 10,472 | |||||||||||||||
Mortgages |
| | | 26,012 | 26,012 | |||||||||||||||
Private loans |
| | | 927 | 927 | |||||||||||||||
Deposits with financial institutions |
| | | 452 | 452 | |||||||||||||||
Policy loans |
| | | 2,180 | 2,180 | |||||||||||||||
Receivables out of share lease agreements |
| | | 19 | 19 | |||||||||||||||
Other |
887 | 1,944 | | 146 | 2,977 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
December 31, 2011 |
105,860 | 5,531 | 168 | 29,736 | 141,295 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
AFS | FVTPL | HTM | Loans | Total | ||||||||||||||||
Shares |
1,298 | 1,078 | | | 2,376 | |||||||||||||||
Debt securities |
94,936 | 1,789 | 139 | | 96,864 | |||||||||||||||
Money market and other short term investments |
10,141 | 659 | | | 10,800 | |||||||||||||||
Mortgages |
| | | 23,781 | 23,781 | |||||||||||||||
Private loans |
| | | 829 | 829 | |||||||||||||||
Deposits with financial institutions |
| | | 748 | 748 | |||||||||||||||
Policy loans |
| | | 2,169 | 2,169 | |||||||||||||||
Receivables out of share lease agreements |
| | | 25 | 25 | |||||||||||||||
Other |
875 | 1,786 | | 151 | 2,812 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
December 31, 2010 |
107,250 | 5,312 | 139 | 27,703 | 140,404 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
Government bond investments
Unaudited |
Page 18 |
Dec. 31, 2011 | Dec. 31, 2010 | |||||||||||||||
EUR millions |
Amortized cost | Fair value | Amortized cost | Fair value | ||||||||||||
Portugal |
13 | 7 | 33 | 32 | ||||||||||||
Italy |
46 | 38 | 114 | 112 | ||||||||||||
Ireland |
30 | 26 | 37 | 32 | ||||||||||||
Greece |
1 | 1 | 58 | 45 | ||||||||||||
Spain |
1,022 | 962 | 1,008 | 904 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
1,112 | 1,034 | 1,250 | 1,125 | ||||||||||||
|
|
|
|
|
|
|
|
15. Investments for account of policyholders
EUR millions |
Dec. 31, 2011 | Dec. 31, 2010 | ||||||
Shares |
37,108 | 40,810 | ||||||
Debt securities |
27,376 | 30,426 | ||||||
Money market and short-term investments |
2,283 | 2,597 | ||||||
Deposits with financial institutions |
2,813 | 2,630 | ||||||
Separate accounts and unconsolidated investment funds |
71,284 | 68,089 | ||||||
Other |
533 | 551 | ||||||
|
|
|
|
|||||
Total investments for account of policyholders at fair value through profit or loss, excluding derivatives |
141,397 | 145,103 | ||||||
Investment in real estate |
1,132 | 1,134 | ||||||
|
|
|
|
|||||
Total investments for account of policyholders |
142,529 | 146,237 | ||||||
|
|
|
|
Unaudited |
Page 19 |
18. Deferred expenses and rebates
EUR millions |
Dec. 31, 2011 | Dec. 31, 2010 | ||||||
DPAC for insurance contracts and investment contracts with discretionary participation features |
11,027 | 11,341 | ||||||
Deferred transaction costs for investment management services |
405 | 380 | ||||||
Unamortized interest rate rebates |
201 | 227 | ||||||
|
|
|
|
|||||
Total deferred expenses and rebates |
11,633 | 11,948 | ||||||
|
|
|
|
19. Share capital
EUR millions |
Dec. 31, 2011 | Dec. 31, 2010 | ||||||
Share capital - par value |
310 | 278 | ||||||
Share premium |
8,787 | 7,906 | ||||||
|
|
|
|
|||||
Total share capital |
9,097 | 8,184 | ||||||
|
|
|
|
|||||
Share capital - par value |
||||||||
Balance at January 1 |
278 | 278 | ||||||
Issuance |
32 | | ||||||
|
|
|
|
|||||
Balance |
310 | 278 | ||||||
|
|
|
|
|||||
Share premium |
||||||||
Balance at January 1 |
7,906 | 7,906 | ||||||
Issuance |
881 | | ||||||
|
|
|
|
|||||
Balance |
8,787 | 7,906 | ||||||
|
|
|
|
Unaudited |
Page 20 |
20. Convertible core capital securities
21. Borrowings
EUR millions |
Dec. 31, 2011 | Dec. 31, 2010 | ||||||
Debentures and other loans |
9,199 | 7,742 | ||||||
Commercial paper |
646 | 701 | ||||||
Short term deposits |
18 | 18 | ||||||
Bank overdrafts |
278 | 57 | ||||||
|
|
|
|
|||||
Total borrowings |
10,141 | 8,518 | ||||||
|
|
|
|
Unaudited |
Page 21 |
22. Commitments and contingencies
23. Acquisitions / Divestments
Acquisitions
Unaudited |
Page 22 |
24. Events after the balance sheet date
Unaudited |
Page 23 |
Disclaimer
Cautionary note regarding non-GAAP measures
This document includes the non-GAAP financial measure: underlying earnings before tax. The reconciliation of underlying earnings before tax to the most comparable IFRS measure is provided in Note 3 Segment information of our Condensed consolidated interim financial statements. AEGON believes that this non-GAAP measure, together with the IFRS information, provides a meaningful measure for the investment community to evaluate AEGONs business relative to the businesses of our peers.
Local currencies and constant currency exchange rates
This document contains certain information about our results and financial condition in USD for the Americas and GBP for the United Kingdom, because those businesses operate and are managed primarily in those currencies. Certain comparative information presented on a constant currency basis eliminates the effects of changes in currency exchange rates. None of this information is a substitute for or superior to financial information about us presented in EUR, which is the currency of our primary financial statements.
Forward-looking statements
The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to our company. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. We undertake no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:
| changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; |
| changes in the performance of financial markets, including emerging markets, such as with regard to: |
| the frequency and severity of defaults by issuers in our fixed income investment portfolios; and |
| the effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities we hold; |
| the effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that we hold; |
| changes in the performance of our investment portfolio and decline in ratings of our counterparties; |
| consequences of a potential (partial) break-up of the euro; |
| the frequency and severity of insured loss events; |
| changes affecting mortality, morbidity, persistence and other factors that may impact the profitability of our insurance products; |
| reinsurers to whom we have ceded significant underwriting risks may fail to meet their obligations; |
| changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; |
| changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness; |
| increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; |
| changes in laws and regulations, particularly those affecting our operations, ability to hire and retain key personnel, the products we sell, and the attractiveness of certain products to our consumers; |
| regulatory changes relating to the insurance industry in the jurisdictions in which we operate; |
| acts of God, acts of terrorism, acts of war and pandemics; |
| changes in the policies of central banks and/or governments; |
| lowering of one or more of our debt ratings issued by recognized rating organizations and the adverse impact such action may have on our ability to raise capital and on our liquidity and financial condition; |
| lowering of one or more of insurer financial strength ratings of our insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability of its insurance subsidiaries and liquidity; |
| the effect of the European Unions Solvency II requirements and other regulations in other jurisdictions affecting the capital we are required to maintain; |
| litigation or regulatory action that could require us to pay significant damages or change the way we do business; |
| as our operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt our business, damage our reputation and adversely affect our results of operations, financial condition and cash flows; |
| customer responsiveness to both new products and distribution channels; |
| competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for our products; |
| changes in accounting regulations and policies may affect our reported results and shareholders equity; |
| the impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including our ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; |
| catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt our business; and |
| our failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives. |
Further details of potential risks and uncertainties affecting the company are described in the companys filings with Euronext Amsterdam and the US Securities and Exchange Commission, including the Annual Report on Form 20-F. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the companys expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Unaudited |
Page 24 |
CORPORATE AND SHAREHOLDER INFORMATION
HEADQUARTERS
AEGON N.V.
P.O. Box 85
2501 CB The Hague
The Netherlands
Telephone: + 31 70 344 32 10
www.aegon.com
GROUP CORPORATE COMMUNICATIONS & INVESTOR RELATIONS
AEGON N.V.
P.O. Box 85
2501 CB The Hague
The Netherlands
MEDIA
Telephone: | + 31 70 344 83 44 | |
E-mail: | gcc-ir@aegon.com | |
ANALYSTS AND INVESTORS | ||
Telephone: | + 31 70 344 83 05 or + 1 877 548 96 68 - toll free USA only | |
E-mail: | ir@aegon.com |
PUBLICATION FIGURES IN 2012
Thursday, May 10, 2012 | Results first quarter 2012 | |
Thursday, August 9, 2012 | Results second quarter 2012 | |
Thursday, November 8, 2012 | Results third quarter 2012 |
PRESS RELEASE AND SUPPLEMENTS
AEGONs Q4 2011 press release and Q4 2011 Financial Supplement are available on AEGONs website www.aegon.com.
Unaudited |
Page 25 |
ABOUT AEGON
Throughout their working lives and into retirement, millions of people around the world rely on AEGON to help them secure their long-term financial futures.
As an international life insurance, pension and investment company, AEGON has businesses in over twenty markets in the Americas, Europe and Asia. AEGON companies employ approximately 25,000 people and serve some 40 million customers across the globe.
AEGON uses its strength and expertise to create added value for customers, employees, shareholders and the wider community. AEGON does this by encouraging innovation and by growing its businesses profitably and sustainably.
AEGONs ambition is to be a leader in all its chosen markets.